Standard BioTools, Inc. (LAB)
0.6276
-0.08
(-11.28%)
USD |
NASDAQ |
Nov 16, 13:35
Standard BioTools EPS Diluted (Quarterly) : -0.0419 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0419 |
| June 30, 2026 | -0.0685 |
| March 31, 2026 | -0.1165 |
| December 31, 2025 | 0.0501 |
| September 30, 2025 | -0.0906 |
| June 30, 2025 | -0.0879 |
| March 31, 2025 | -0.0688 |
| December 31, 2024 | -0.091 |
| September 30, 2024 | -0.0725 |
| June 30, 2024 | -0.1228 |
| March 31, 2024 | -0.2658 |
| December 31, 2023 | -0.248 |
| September 30, 2023 | -0.2653 |
| June 30, 2023 | -0.2166 |
| March 31, 2023 | -0.213 |
| December 31, 2022 | -0.2624 |
| September 30, 2022 | -0.373 |
| June 30, 2022 | -0.8165 |
| March 31, 2022 | -0.9904 |
| December 31, 2021 | -0.123 |
| September 30, 2021 | -0.1814 |
| June 30, 2021 | -0.2272 |
| March 31, 2021 | -0.2519 |
| December 31, 2020 | -0.2427 |
| September 30, 2020 | -0.0828 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.1835 |
| March 31, 2020 | -0.2268 |
| December 31, 2019 | -0.182 |
| September 30, 2019 | -0.1855 |
| June 30, 2019 | -0.1989 |
| March 31, 2019 | -0.436 |
| December 31, 2018 | -0.3561 |
| September 30, 2018 | -0.3759 |
| June 30, 2018 | -0.42 |
| March 31, 2018 | -0.34 |
| December 31, 2017 | -0.27 |
| September 30, 2017 | -0.46 |
| June 30, 2017 | -0.58 |
| March 31, 2017 | -0.59 |
| December 31, 2016 | -0.61 |
| September 30, 2016 | -0.68 |
| June 30, 2016 | -0.64 |
| March 31, 2016 | -0.69 |
| December 31, 2015 | -0.45 |
| September 30, 2015 | -0.32 |
| June 30, 2015 | -0.53 |
| March 31, 2015 | -0.56 |
| December 31, 2014 | -0.39 |
| September 30, 2014 | -0.49 |
| June 30, 2014 | -0.45 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.279 |
| Bio-Rad Laboratories, Inc. | 17.02 |
| Bruker Corp. | -0.8052 |
| Danaher Corp. | 1.747 |
| Harvard Bioscience, Inc. | -0.5751 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.98M |
| Revenue (Quarterly) | 19.38M |
| Total Expenses (Quarterly) | 34.36M |
| Enterprise Value | -155.09M |
| Gross Profit Margin (Quarterly) | 55.86% |
| Profit Margin (Quarterly) | -77.26% |
| Earnings Yield | -28.17% |
| Normalized Earnings Yield | -18.18 |